
Spinifex Pharmaceuticals
Clinical-stage biotechnology company specializing in the development of products for the treatment of pain.
Employees
Enterprise value
$200m
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
investor investor investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
$200m Valuation: $200m | Acquisition | ||
Total Funding | 000k |

Uniseed Ventures(exited)

Canaan(exited)

Novo Holdings(exited)

Novo Seeds(exited)

Brandon Capital Partners(exited)

GBS Venture Partners(exited)

Uniseed(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads